|
41
|
217
|
3lh1A |
Q191a mutant of the degs-deltapdz |
|
42
|
211
|
3lt3A |
Crystal structure of rv3671c from m. tuberculosis h37rv, ser343ala mutant, inactive form |
|
42
|
217
|
3lguA |
Y162a mutant of the degs-deltapdz protease |
|
37
|
181
|
3lonA |
Hcv ns3-4a protease domain with ketoamide inhibitor narlaprevir |
|
36
|
213
|
3lgyA |
R178a mutant of the degs-deltapdz protease |
|
53
|
198
|
3lprA |
Structural basis for broad specificity in alpha-lytic protease mutants |
|
55
|
223
|
3ljoA |
Bovine trypsin in complex with ub-thr 11 |
|
43
|
215
|
3lgtA |
Y162a/h198p double mutant of degs-deltapdz protease |
|
45
|
216
|
3lh3A |
Dfp modified degs delta pdz |
|
32
|
230
|
3lkwA |
Crystal structure of dengue virus 1 ns2b/ns3 protease active site mutant |
|
56
|
220
|
3lgiA |
Structure of the protease domain of degs (degs-deltapdz) at 1.65 a |
|
57
|
234
|
3liwA |
Factor xa in complex with (r)-2-(1-adamantylcarbamoylamino)-3-(3-carbamidoyl-phenyl)-n-phenethyl-propionic acid amide |
|
58
|
257
|
3ldxH |
Discovery and clinical evaluation of rwj-671818, a thrombin inhibitor with an oxyguanidine p1 motif |
|
58
|
257
|
3lu9B |
Crystal structure of human thrombin mutant s195a in complex with the extracellular fragment of human par1 |
|
46
|
217
|
3lgvA |
H198p mutant of the degs-deltapdz protease |
|
39
|
217
|
3lgwA |
H198p/t167v double mutant of degs-deltapdz protease |
|
37
|
181
|
3loxA |
Hcv ns3-4a protease domain with a ketoamide inhibitor derivative of boceprevir bound |
|
57
|
223
|
3ljjA |
Bovine trypsin in complex with ub-thr 10 |
|
51
|
235
|
3lc5A |
Selective benzothiophine inhibitors of factor ixa |
|
50
|
231
|
3kyfA |
Crystal structure of p4397 complexed with c-di-gmp |
|
52
|
224
|
3l33A |
Human mesotrypsin complexed with amyloid precursor protein inhibitor(appi) |
|
29
|
221
|
3l6pA |
Crystal structure of dengue virus 1 ns2b/ns3 protease |
|
39
|
227
|
3kygA |
Crystal structure of vca0042 (l135r) complexed with c-di-gmp |
|
55
|
224
|
3l3tA |
Human mesotrypsin complexed with amyloid precursor protein inhibitor variant (appir15k) |
|
53
|
235
|
3lc3A |
Benzothiophene inhibitors of factor ixa |
|
60
|
234
|
3kqbA |
Factor xa in complex with the inhibitor n-(3-fluoro-2'- (methylsulfonyl)biphenyl-4-yl)-1-(3-(5-oxo-4,5-dihydro-1h- 1,2,4-triazol-3-yl)phenyl)-3-(trifluoromethyl)-1h- pyrazole-5-carboxamide |
|
49
|
246
|
3kidU |
The crystal structures of 2-aminobenzothiazole-based inhibitors in complexes with urokinase-type plasminogen activator |
|
118
|
376
|
3kq5A |
Crystal structure of an uncharacterized protein from coxiella burnetii |
|
36
|
154
|
3kf2A |
The hcv ns3/ns4a protease apo structure |
|
60
|
234
|
3kqcA |
Factor xa in complex with the inhibitor 6-(2'- (methylsulfonyl)biphenyl-4-yl)-1-(3-(5-oxo-4,5-dihydro-1h- 1,2,4-triazol-3-yl)phenyl)-3-(trifluoromethyl)-5,6- dihydro-1h-pyrazolo[3,4-c]pyridin-7(4h)-one |
|
55
|
246
|
3khvA |
Crystal structures of urokinase-type plasminogen activator in complex with 4-(aminomethyl) benzoic acid and 4-(aminomethyl-phenyl)-methanol |
|
43
|
178
|
3keeA |
Hcv ns3/ns4a complexed with non-covalent macrocyclic compound tmc435 |
|
42
|
181
|
3kn2A |
Hcv ns3 protease domain with ketoamide inhibitor |
|
56
|
235
|
3kcgH |
Crystal structure of the antithrombin-factor ixa-pentasaccharide complex |
|
42
|
181
|
3knxA |
Hcv ns3 protease domain with p1-p3 macrocyclic ketoamide inhibitor |
|
61
|
238
|
3k9xB |
X-ray crystal structure of human fxa in complex with (s)-n-((2-methylbenzofuran-5-ylamino)(2-oxo-1-(2-oxo-2- (pyrrolidin-1-yl)ethyl)azepan-3- ylamino)methylene)nicotinamide |
|
60
|
234
|
3kqeA |
Factor xa in complex with the inhibitor 3-methyl-1-(3-(5- oxo-4,5-dihydro-1h-1,2,4-triazol-3-yl)phenyl)-6-(2'- (pyrrolidin-1-ylmethyl)biphenyl-4-yl)-5,6-dihydro-1h- pyrazolo[3,4-c]pyridin-7(4h)-one |
|
54
|
232
|
3kl6A |
Discovery of tetrahydropyrimidin-2(1h)-one derivative tak-442: a potent, selective and orally active factor xa inhibitor |
|
55
|
234
|
3kqdA |
Factor xa in complex with the inhibitor 1-(3-(5-oxo-4,5- dihydro-1h-1,2,4-triazol-3-yl)phenyl)-6-(2'-(pyrrolidin-1- ylmethyl)biphenyl-4-yl)-3-(trifluoromethyl)-5,6-dihydro- 1h-pyrazolo[3,4-c]pyridin-7(4h)-one |
|
54
|
245
|
3kgpA |
Crystal structures of urokinase-type plasminogen activator in complex with 4-(aminomethyl) benzoic acid and 4-(aminomethyl-phenyl)-methanol |
|
55
|
259
|
3jz1B |
Crystal structure of human thrombin mutant n143p in e:na+ form |
|
50
|
239
|
3k2uA |
Crystal structure of hgfa in complex with the allosteric inhibitory antibody fab40 |
|
51
|
227
|
3k6yA |
Crystal structure of rv3671c protease from m. tuberculosis, active form |
|
43
|
205
|
3k6zA |
Crystal structure of rv3671c protease, inactive form |
|
53
|
257
|
3jz2B |
Crystal structure of human thrombin mutant n143p in e* form |
|
74
|
299
|
3k65B |
Crystal structure of prethombin-2/fragment-2 complex |
|
62
|
301
|
3iwmA |
The octameric sars-cov main protease |
|
54
|
223
|
3itiA |
Structure of bovine trypsin with the mad triangle b3c |
|
64
|
233
|
3iitA |
Factor xa in complex with a cis-1,2-diaminocyclohexane derivative |
|
341
|
964
|
3h09A |
The structure of haemophilus influenzae iga1 protease |
